Variant allele frequency: a decision-making tool in precision oncology?
2023 · Trends in cancer · 71 citations
https://doi.org/10.1016/j.trecan.2023.08.011
L
Luca Boscolo Bielo
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
49
Papers
484
Citations
12
h-index
16
i10-index
Luca Boscolo Bielo is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Cancer Genomics and Diagnostics & Lung Cancer Treatments and Mutations & HER2/EGFR in Cancer Research. The author has an h-index of 12, co-authored 42 publications.
ORCID: 0000-0003-1026-3923Papers by this author
worksNeoadjuvant therapy in hormone Receptor-Positive/HER2-Negative breast cancer
2023 · Cancer Treatment Reviews · 39 citations
https://doi.org/10.1016/j.ctrv.2023.102669
Mismatch repair (MMR) and microsatellite instability (MSI) phenotypes across solid tumors: A comprehensive cBioPortal study on prevalence and prognostic impact
2025 · European Journal of Cancer · 20 citations
https://doi.org/10.1016/j.ejca.2025.115233
Comprehensive genomic profiling by liquid biopsy portrays metastatic colorectal cancer mutational landscape to predict antitumor efficacy of FOLFIRI plus cetuximab in the CAPRI-2 GOIM trial
2025 · ESMO Open · 11 citations
https://doi.org/10.1016/j.esmoop.2025.104511
Antibody-Drug Conjugates in Breast Cancer: What Is Beyond HER2?
2022 · The Cancer Journal · 10 citations
https://doi.org/10.1097/ppo.0000000000000629
Genomic and clinical landscape of metastatic hormone receptors-positive breast cancers carrying ESR1 alterations
2024 · ESMO Open · 8 citations
https://doi.org/10.1016/j.esmoop.2024.103731
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat